Based on 12 analysts giving stock ratings to Surgery Partners Inc in the past month.
In the current month, SGRY has received 6 Buy Ratings, 3 Hold Ratings, and 0 Sell Ratings. SGRY average Analyst price target in the last month is 22.167.
Based on analysts' estimates, SGRY EPS is projected to reach 0.120 in FY2026Q3, following reported EPS of -0.116 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
The market expectation was USD -0.12, while Surgery Partners IncSGRY's earnings per share (EPS) for the previous quarter was USD -0.28. EPS for the next quarter is expected at USD 0.12.